Cargando…

Cell biological steps and checkpoints in accessing NK cell cytotoxicity

Natural killer (NK) cell-mediated cytotoxicity is governed by the formation of a lytic immune synapse in discrete regulated steps, which give rise to an extensive array of cellular checkpoints in accessing NK cell-mediated cytolytic defense. Appropriate progression through these cell biological step...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mace, Emily M, Dongre, Prachi, Hsu, Hsiang-Ting, Sinha, Papiya, James, Ashley M, Mann, Shaina S, Forbes, Lisa R, Watkin, Levi B, Orange, Jordan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960583/ https://www.ncbi.nlm.nih.gov/pubmed/24445602 http://dx.doi.org/10.1038/icb.2013.96

Ejemplares similares

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing
por: Hsu, Hsiang-Ting, et al.
Publicado: (2016)

New views of the human NK cell immunological synapse: recent advances enabled by super- and high-resolution imaging techniques
por: Mace, Emily M., et al.
Publicado: (2013)

Human NK cell development requires CD56-mediated motility and formation of the developmental synapse
por: Mace, Emily M., et al.
Publicado: (2016)

High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults
por: Mahapatra, Sanjana, et al.
Publicado: (2017)

Editorial: NK Cell Subsets in Health and Disease: New Developments
por: Marcenaro, Emanuela, et al.
Publicado: (2017)

Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis
por: Li, Yu, et al.
Publicado: (2021)

NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019)

Dual channel STED nanoscopy of lytic granules on actin filaments in natural killer cells
por: Mace, Emily M., et al.
Publicado: (2012)

CD56 regulates human NK cell cytotoxicity through Pyk2
por: Gunesch, Justin T, et al.
Publicado: (2020)

Myosin IIA is required for cytolytic granule exocytosis in human NK cells
por: Andzelm, Milena M., et al.
Publicado: (2007)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

NK Cell-Based Immune Checkpoint Inhibition
por: Khan, Muhammad, et al.
Publicado: (2020)

An ELF4 hypomorphic variant results in NK cell deficiency
por: Salinas, Sandra Andrea, et al.
Publicado: (2022)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

The Autoimmune Disorder Susceptibility Gene CLEC16A Restrains NK Cell Function in YTS NK Cell Line and Clec16a Knockout Mice
por: Pandey, Rahul, et al.
Publicado: (2019)

Cysteine Cathepsins as Regulators of the Cytotoxicity of NK and T Cells
por: Perišić Nanut, Milica, et al.
Publicado: (2014)

The negative NK cell maturation checkpoint Foxo1
por: Deng, Youcai, et al.
Publicado: (2015)

Control of NK Cell Activation by Immune Checkpoint Molecules
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2017)

The Emerging Role of NK Cells in Immune Checkpoint Blockade
por: Martinez-Perez, Alejandra, et al.
Publicado: (2022)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
por: Yang, Yan, et al.
Publicado: (2020)

Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia
por: Conte, Matilde I., et al.
Publicado: (2022)

Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
por: Barilà, Gregorio, et al.
Publicado: (2018)

Novel Heterozygous Mutation in NFKB2 Is Associated With Early Onset CVID and a Functional Defect in NK Cells Complicated by Disseminated CMV Infection and Severe Nephrotic Syndrome
por: Aird, Alejandra, et al.
Publicado: (2019)

Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy
por: Anvari, Sara, et al.
Publicado: (2022)

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

The SIRPα–CD47 immune checkpoint in NK cells
por: Deuse, Tobias, et al.
Publicado: (2021)

Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
por: Chan, Jason Yongsheng, et al.
Publicado: (2021)

Formation of a WIP-, WASp-, actin-, and myosin IIA–containing multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling
por: Krzewski, Konrad, et al.
Publicado: (2006)

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans
por: Naujoks, Wiebke, et al.
Publicado: (2020)

p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
por: Wong, Derek P., et al.
Publicado: (2023)

Microchip Screening Platform for Single Cell Assessment of NK Cell Cytotoxicity
por: Guldevall, Karolin, et al.
Publicado: (2016)

Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology
por: Metgud, Rashmi S, et al.
Publicado: (2011)

Acquisition of cell migration defines NK cell differentiation from hematopoietic stem cell precursors
por: Lee, Barclay J., et al.
Publicado: (2017)

Editorial: Molecular and Cellular Pathways in NK Cell Development
por: Sitnicka, Ewa, et al.
Publicado: (2020)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma
por: Wu, Ting, et al.
Publicado: (2015)

Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2020)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ii20vbsalrlj5l6nblv0mfi4os